Can we defeat meningococcal disease in low and middle income countries?

► Meningococcal vaccination policies must be guided by sound epidemiological data. ► Information on the burden of meningococcal disease is lacking in many developing countries. ► Lack of information on the cost effectiveness of meningococcal vaccines hinders uptake in middle income countries. ► Development of new meningococcal vaccines makes global control of meningococcal disease a feasible objective.